That is very important, because the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. In other words, we have to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error process (biotech stocks). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're developed to do. This was a development almost no one saw. However it's going to have extensive implications for treating illness. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be plenty of investment opportunities in this space, too. Moving topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (first lady). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it pulled back maybe significantly prior to going greater - jeff brown 2020 predictions. I have actually been covering bitcoin for a long period of time now. Among the very first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were mostly educating readers. However that's not the huge question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. exponential tech investor. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are numerous fantastic personal business on the edge of hitting the general public markets And I've been working on a brand-new way for you to invest even before these companies go public.
This chance has actually been building over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to reserve your spot totally free.
Emma Walsh here, handling editor of the Journal. Regular Journal readers know that tech isn't our usual beat (biotech stocks). And when it pertains to tech investing, we leave it to the specialists. Thankfully, we have several such professionals in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing experts we know (democratic republic). In reality, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big image and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing exponential development and creating unbelievable chances for investors. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. jeff brown. But regardless of what numerous readers may think, this is a pattern that's just starting. Although the COVID-19 pandemic disrupted supply chains in 2015, an excellent 250 million 5G-enabled devices were still sold.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (artificial intelligence). Losing two months of production and sales actually impacts how many 5G devices are sold in the fiscal year. When you consider all of that, offering 250 million systems is remarkable. More significantly, the delays triggered by the pandemic produced a lots of pent-up need. Which need is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G gadgets will be delivered in 2021 - toxic tech 5 tech darlings. Which's not my only 5G forecast When I've spoken about 5G in the past, I have actually explained its three different phases.
In Stage Two, 5G devices go on sale. 5G phones and other items start to reach consumers. And in Phase Three, 5G services begin to be used (future report). That's when we begin to see applications operating on 5G networks. Consider things like enormous multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Stage Three by this summertime. This begins something of a virtuous cycle: Many people don't truly care about the technology. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In truth, 5G is going to open a suite of unbelievable applications: self-driving automobiles, the Internet of Things, robotic surgical treatment, and more. All of these innovations require 5G. The financial investment opportunities going forward will be enormous. Stepping away from 5G, the next essential innovation I foresee in 2021 is CRISPR hereditary editing. CRISPR stands for "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it's one of the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software.
The program can crash or not function correctly. CRISPR uses a comparable idea however with our hereditary code. "Typos" in our genome can result in disease. CRISPR can fix these "typos." For many years, CRISPR was primarily a specific niche technology that wasn't well comprehended. And throughout that time, there were actually just 3 business operating in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing actual results. We're dealing with illness and seeing that this technology just works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and delivering incredible returns. This whole industry is effectively a greenfield chance.
There's space for lots of business to exist in this space. genetic sequencing companies jeff brown. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or 3 more hereditary modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things occurring at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software application can properly anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is necessary because the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable.
Historically, this has actually been a trial-and-error process. Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but numerous drug therapies produced using this innovation. This was one of those breakthroughs that nearly nobody observed. But it's going to have profound implications for curing illness. And, of course, there will be lots of investment chances in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it pulled back maybe substantially prior to going greater. I've been covering bitcoin for a long time now. Among the very first research reports I ever published was on bitcoin - last year. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my recommendation. However at the time of that initial recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. self-driving cars. Mass, Mutual is a 150-year-old organization. So think about that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the information depends on date as of February 2021, but we could not separately validate this claim. Given Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an exact figure at this minute. Brown is best understood for his sage-like capability to pick winning innovation stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an outstanding viewpoint on the marketplace. He's always on the hunt for brand-new chances, and he shares a lot of his finest choices in the Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an exceptional reputation as a stock-picker, and he effectively anticipated some of the most significant financial occasions of the previous twenty years. Although he does not appear to launch his picks to the public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it ideal each time, but Jeff Brown's accurate forecasts have earned him legions of devoted fans. That states a lot about his ability. The Future Report is published by Brownstone Research study, a popular monetary research study publisher. Brownstone Research study offers numerous research services with a wide array of specializations - jeff brown biotech stock.
The company is also affiliated with Bonner & Partners, another well-respected research study publisher - self-driving cars. On its site, Brownstone states its objective is to supply retail financiers with professional-grade research study: "For too long, the very best financial investment research study has not been offered to individual investors. It has been typically reserved for financial investment banks, hedge funds, personal equity, and high-net-worth customers. tech stocks. The mission of Brownstone Research is to make that type of exclusive research offered to any financiers seeking to acquire an edge in the marketplaces. The objective is easy to deliver special and successful investment research discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise acts as the company's Chief Investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After decades of stable success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a home name throughout the majority of America. If you know even a little bit about the marketplace, you know that he has a reputation as a King Midas of sorts. jeff brown stock picks 2021. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In fact, Brown thinks S.A.V. bleeding edge. could be "the most significant pattern of the 2020s, and he's not alone. Check out these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying 2 advanced technologies: expert system and electric cars and trucks. Musk hopes the combination will help him establish the first fully-autonomous, self-driving cars ever. It's nothing except the automobile market's Holy Grail. As you know, electrical cars and self-driving automobile stocks have actually been huge this year, but the Wall Street maker has approved hype without much concrete result. Despite an extreme increase in competitors over the past couple of years, Brown still believes Musk has the finest chance of putting all of it together.
tech could be the magic string that ties it all together. S.A.V. stands for Shared Autonomous Automobile, and it could be the future of transport. Generally, this technology would allow you to lease your car as a self-governing, self-driving taxi when you're not utilizing it. You simply get out of the vehicle and press a button on an app that tells the automobile to "join the fleet." Next thing you know, you're relaxing on your sofa while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a large portion of the revenues. It sounds ridiculous, however it might be closed than you believe.